Filing Details
- Accession Number:
- 0001567619-19-006067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 18:40:32
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 18:40:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-28 | 1,019 | $57.92 | 36,694 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-03-01 | 2,024 | $58.20 | 34,670 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.52 to $58.49, inclusive.